Медицинский совет, 2014 The article tells about prevention of ischemic stroke (IS) in patients after IS or transient ischemic attack (TIA) against a background of non-valvular atrial fibrillation (AF).
V. A. Parfyonov, S. V. Verbitskaya
doaj +1 more source
ДАБИГАТРАН И ИДАРУЦИЗУМАБ. НОВЫЕ ВОЗМОЖНОСТИ ОБЕСПЕЧЕНИЯ БЕЗОПАСНОСТИ ПАЦИЕНТОВ [PDF]
, 2019 The widespread use of new oral anticoagulants in clinical practice requires improving the safety of medication use, i.e. the use of specific reversal agents, if necessary. Idarucizumab, a humanied monoclonal antibody fragment, is the first reversal agent
A. Volovchenko N. +5 more
core +4 more sources
Показатели внутрисосудистой активации тромбоцитов у пациентов с тромбозами магистральных вен нижних конечностей [PDF]
, 2015 ТРОМБОЦИТОВ АКТИВАЦИЯГЕМОСТАЗТРОМБОЗ ВЕНОЗНЫЙКОНЕЧНОСТЬ ...
Орел, М. Г.
core +1 more source
NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
Рациональная фармакотерапия в кардиологии, 2015 Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including dabigatran, rivaroxaban and apixaban) is presented from the standpoint of safety.
D. A. Napalkov, A. A. Sokolova
doaj +1 more source
Differences in the activity of coagulation cascade factors and concentrations of fibrinogen and d-dimer, in patients with pulmonary thromboembolism on direct oral anticoagulant therapy [PDF]
, 2023 Терапија директним оралним антикоагулансима (ДОАК) је према савременим водичима препоручена за лечење пацијената са плућном тромбоемболијом (ПТЕ). Није познато на који начин ДОАК-и утичу на активност фактора коагулације који нису њихова директна мета ...
Џудовић, Jелена
core
ПРОФИЛАКТИКА ТРОМБОЭМБОЛИЧЕСКИХ ОСЛОЖНЕНИЙ ПОСЛЕ КАТЕТЕРНОЙ АБЛАЦИИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ С ПОМОЩЬЮ ДАБИГАТРАНА [PDF]
, 2015 In the survey, the results of the largest comparative studies on the efficacy and safety of dabigatran and warfarin for the prevention of thromboembolic complications in patients underwent atrial fibrillation catheter ablation are discussed.В обзорной ...
D. Scherbinina A. +7 more
core +2 more sources
Management Of Oral Anticoagulation In Patients, Undergoing Elective Surgery Or Invasive Procedures [PDF]
, 2020 Oral anticoagulants play a key role in prevention and treatment of cardiovascular diseases. In the last years, the number of patients taking oral anticoagulants is growing and we have more medicaments in use.
Hadjiveli, Aylin, Kisheva, Antoniya
core +2 more sources
ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
Рациональная фармакотерапия в кардиологии, 2016 New data and perspectives of antithrombotic therapy are highlighted in patients with atrial fibrillation. Factors of warfarin therapy efficacy, as well as the possibility of new antithrombotic drugs are considered.
M. Yu. Gilyarov, V. A. Sulimov
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 The clinical significance of the patient genetic characteristics in the individual pharmacological response to oral anticoagulants is considered. Possible tactics of warfarin dosing and new oral anticoagulants choice on the basis of pharmacogenetic ...
D. A. Sychev +3 more
doaj +1 more source
Ближайшие и отдаленные результаты применения дабигатрана в комплексном лечении венозного тромбоэмболизма [PDF]
, 2011 ВАРФАРИНДАБИГАТРАНТРОМБОЭМБОЛИЗ
Савчук, О. Ф. +1 more
core